CDKN1A and cancer: These promiscuous protein interactions have been observed in various proteins associated with cancer development including p53, cyclin-dependent kinase (CDK) inhibitors p21Waf1/Cip1/Sdi1, p27Kip1 and breast cancer type-1 susceptibility protein (BRCA1)10–13.